Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 49

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 49
---
 constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act. The address of each of BML, BML Capital Management, LLC and Braden M. Leonard is 65 E Cedar, Suite 2, Zionsville, Indiana 46077. |

| (5) | Based on a Schedule 13G filed with the SEC on February 21, 2025, consists of 2,598,827 shares held by PFM Biotech Opportunities LP (“BO”). PFM Health Sciences, LP (“PFM”) is the investment advisor of BO and Partner Asset Management, LLC (“PAM”) is the general partner of BO. PFM Health Sciences GP, LLC (“PFM-GP”) is the general partner of PFM and the manager of PAM. Brian D. Grossman is the sole member of PFM-GP. Each of PFM, PAM, PFM-GP and Mr. Grossman may be deemed to have shared voting power and shared dispositive power over such shares held by BO, and thus may be deemed to beneficially own such shares held by BO. The address of each of BO, PFM, PAM, PFM-GP and Mr. Grossman is c/o PFM Health Sciences, LP, 475 Sansome Street, Suite 1720, San Francisco, California 94111. |

| (6) | Consists of (i) 147,915 shares of common stock held by The Mack-Mulligan Revocable Trust, of which Dr. Mack’s descendants are beneficiaries, (ii) 56,978 shares of common stock held by The Mack/Mulligan 2020 Irrevocable Descendants’ Trust, of which Dr. Mack’s descendants are beneficiaries, (iii) 165,307 shares of common stock held by Stinson 2021 Irrevocable Trust, of which Dr. Mack’s spouse and descendants are beneficiaries, (iv) 579,016 shares of common stock held directly by Dr. Mack and (v) 1,135,295 shares of common stock issuable pursuant to options held directly by Dr. Mack, exercisable within 60 days of April 8, 2025. Dr. Mack disclaims beneficial ownership of all shares relating to The Mack-Mulligan Revocable Trust, The Mack/Mulligan 2020 Irrevocable Descendants’ Trust and Stinson 2021 Irrevocable Trust except